MARLBOROUGH, Mass.–(BUSINESS WIRE)–Ocata Therapeutics, Inc. (NASDAQ:OCAT), a leader in the field of Regenerative Ophthalmology™, today announced that it continues to fortify the patent protection covering its retinal pigment epithelium (RPE) transplant technology for macular degeneration with the issuance by the United States Patent and Trademark Office (USPTO) of U.S. Patent No 9,080,150. “The issuance of this 9th U.S. patent in our global RPE portfolio represents yet another example of the
CINCINNATI–(BUSINESS WIRE)–Aerpio Therapeutics, a biopharmaceutical company focused on advancing first-in-class treatments for the eye, today announced top-line results from its TIME-2 study of AKB-9778 in DME. The combination of AKB-9778 (dosed at 15 mg BID) and Lucentis® (ranibizumab injection) provided a clinically significant benefit in reduction of central subfield thickness (CST) compared to Lucentis® alone (p=0.008). In association with this improvement in CST, a positive trend also sh
A collaboration between scientists in the UK and the USA has shown that gene therapy can give life-long protection to the light-sensitive photoreceptor cells responsible for colour vision in a mouse model of the most common inherited eye disorder.
A collaboration between scientists in the UK and the USA has shown that gene therapy can give life-long protection to the light-sensitive photoreceptor cells responsible for colour vision in a mouse…
A 26-year-old female nursing school graduate was referred to the New England Eye Center for decreased vision in both eyes with a normal fundus exam. One month before referral, she noted gradually worsening vision more significant in the right eye than the left. Other than a vague history of back pain and numbness in her right toe, she had no other significant medical or family history. A recent MRI of the brain showed no abnormality.The patient’s best corrected visual acuity was 20/200 in the right eye and 20/30 in the (Read more...)
An evaluation model based on the assessment of postural reactivity using dynamic visual stimuli in a virtual reality environment may help evaluate balance control and associated risk of falling in patients with glaucoma, according to a study.Patients w…